benidipine has been researched along with Diabetic Glomerulosclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Wu, G; Xu, K; Xu, M | 1 |
| Abe, M; Fujita, T; Maruyama, N; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M | 1 |
| Miki, H; Nagashima, K; Yao, K | 1 |
| Hosoi, M; Imanishi, M; Konishi, Y; Masada, M; Miura, K; Morikawa, T; Okada, N; Okumura, M; Shintaku, H; Yoshida, Y | 1 |
1 review(s) available for benidipine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker.
Topics: Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Calcium Channels, T-Type; Clinical Trials as Topic; Diabetic Nephropathies; Dihydropyridines; Drug Evaluation, Preclinical; Endothelial Cells; Heart; Humans; Hypertension; Kidney; Renal Circulation; Vasodilator Agents | 2006 |
1 trial(s) available for benidipine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.
Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Diabetic Nephropathies; Dihydropyridines; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Hypertension; Male; Middle Aged; Nephrosclerosis; Potassium; Severity of Illness Index; Sodium | 2011 |
2 other study(ies) available for benidipine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Benidipine protects kidney through inhibiting ROCK1 activity and reducing the epithelium-mesenchymal transdifferentiation in type 1 diabetic rats.
Topics: Animals; Calcium Channel Blockers; Cell Transdifferentiation; Cytoprotection; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dihydropyridines; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Male; Rats; Rats, Wistar; rho-Associated Kinases | 2013 |
Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats.
Topics: Animals; Biopterins; Blood Glucose; Blood Pressure; Body Weight; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Kidney; Male; Nitric Oxide; Proteinuria; Rats; Rats, Inbred OLETF; Rats, Long-Evans | 2006 |